Clinical trial

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

NCT04902625

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Naltrexone-Bupropion Combination Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-03-21

PhasePHASE4

Conditions

Obesity, Morbidunresolved

Bariatric Surgery Candidateunresolved

Medication Persistenceunresolved

Interventions

Naltrexone-Bupropion CombinationDRUG

Sponsors & collaborators

Zuyderland Medisch Centrumlead sponsor

Nederlandse Obesitas Kliniekcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04902625 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.